8th Annual

Hematology and Medical Oncology Board Review:Contemporary Practice

MARCH 6-9, 2020

Memorial Sloan Kettering Cancer CenterZuckerman Research CenterNew York City

LIVE SIMULCAST AVAILABLE

This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and

management of neoplastic disease, including solid tumor and hematologic oncology.

OVERVIEW

Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology.

By attending this course, attendees will:

• Learn state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers

• Learn state-of-the-science in diagnosis, staging, and therapeutic management of hematologic cancers

• Understand recent treatment advances in solid tumor and hematologic oncology and their impact on modern clinical practice

The target audience for this course is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents.

David H. Ilson, MD, PhDAttending Physician, Gastrointestinal Oncology ServiceDivision of Solid Tumor OncologyDepartment of MedicineMember, Memorial Sloan Kettering Cancer CenterProfessor of Medicine, Weill Cornell Medical College

Paul A. Hamlin, MDMedical Director, David H. Koch Center for Cancer CareAssociate Attending, Lymphoma Service Division of Hematologic Malignancies Department of MedicineAssociate Professor of Medicine, Weill Cornell Medical College

Memorial Sloan Kettering Course Faculty

Ghassan K. Abou-Alfa, MD, MBAAttending Physician Gastrointestinal Oncology Service

Carol Aghajanian, MDAttending Physician, ChiefGynecologic Medical Oncology Service

Dean F. Bajorin, MD, FACPAttending PhysicianGenitourinary Oncology ServiceFrederick R. Adler Senior Faculty Chair

Renier J. Brentjens, MD, PhDDirector, Cellular Therapeutics CenterAttending PhysicianLeukemia Service

Andrea Cercek, MDAssistant Attending PhysicianGastrointestinal Oncology Service

Paul B. Chapman, MDAttending PhysicianMelanoma and Immunotherapeutics service

Hiram S. Cody III, MD, FACSAttending SurgeonBreast ServiceProfessor of Surgery, Weill Cornell Medical College

Chau T. Dang, MDRegional Care Network Medical Site Director, MSK WestchesterAssociate Attending Physician Breast Medicine Service

Mark A. Dickson, MDAssociate Attending PhysicianSarcoma Medical Oncology Service

Darren R. Feldman, MDChair, Quality AssuranceAssistant Attending PhysicianGenitourinary Oncology ServiceAssistant Professor of Medicine, Weill Cornell Medical College

Devika Gajria, MDAssistant Attending Physician Breast Medicine Service

Mrinal M. Gounder, MDAssistant Attending PhysicianSarcoma Medical Oncology ServiceEarly Drug Development Service

Rachel N. Grisham, MD Associate Attending PhysicianGynecologic Medical Oncology Service

Christian Grommes, MDAssistant Attending PhysicianBrain Tumor Service

Komal Jhaveri, MD, FACPAssistant Attending Physician Breast Medicine Service and Early Drug Development Service

Philip Kantoff, MDChairman, Department of MedicineGeorge J. Bosl ChairProfessor of Medicine, Weill Cornell Medical College

W. Victoria Lai, MDAssistant AttendingThoracic Oncology Service

C. Ola Landgren, MD, PhDChief, Myeloma Service

Simon Mantha, MD, MPHAssociate Attending Physician Hematology Service

Anthony Mato, MDDirector, CLL ProgramAssociate Attending PhysicianLeukemia Service

Michael J. Mauro, MDAttending PhysicianLeukemia Service

Beryl McCormick, MD, FACRChief, External Beam Radiotherapy ServiceProfessor of Radiation Oncology, Weill Cornell Medical College

Jodi Mones, MDAssociate AttendingHematology Service

Alison J. Moskowitz, MDClinical Director, Lymphoma Inpatient Unit Assistant AttendingLymphoma Service

Robert J. Motzer, MDAttending PhysicianGenitourinary Oncology ServiceJack and Dorothy Byrne Chair in Clinical Oncology

Eileen M. O’Reilly, MDAssociate Director, David M. Rubenstein Center for Pancreatic CancerAttending Physician, MemberGastrointestinal Oncology ServiceWinthrop Rockefeller Chair in Medical OncologyProfessor of Medicine, Weill Cornell Medical College

David G. Pfister, MDAttending Physician, ChiefHead and Neck Oncology ServiceAssociate Deputy Physician-in-Chief, Strategic Partnerships

Gregory J. Riely, MD, PhDVice Chair, Clinical ResearchAssociate Attending PhysicianThoracic Oncology Service

Leonard B. Saltz, MDExecutive Director for Clinical Value and SustainabilityAttending PhysicianGastrointestinal Oncology ServiceProfessor of Medicine, Weill Cornell Medical College

Craig S. Sauter, MDAssistant AttendingBone Marrow Transplant Service

Neil H. Segal, MD, PhDAssociate AttendingGastrointestinal Oncology Service

Susan K. Seo, MDDirector, Antibiotic Management ProgramAttending PhysicianInfectious Disease service

Gerald A. Soff, MDChief, Hematology Service

Zsofia K. Stadler, MDClinical Director, Clinical Genetics ServiceAttending PhysicianClinical Genetics and Gastrointestinal Oncology Services

Martin S. Tallman, MDChief, Leukemia Service

Anna M. Varghese, MDAssistant Attending PhysicianGastrointestinal Oncology Service

Marjorie G. Zauderer, MDCo-Director MSK Mesothelioma ProgramAssistant Attending PhysicianThoracic Oncology Service

Andrew D. Zelenetz, MD, PhDMedical Director, Quality InformaticsAttending PhysicianLymphoma Service

Memorial Sloan KetteringCourse Directors

Course registration includes access to an online syllabus (with downloadable PDF files and video clips of thepresentations) as well as a USB flash drive*.*USB flash drive only available for non-MSK attendees.

7:30 am Breakfast and Registration

8:00 am Department of Medicine Grand Rounds

Novel Approaches and New Advances in Immunotherapy Treatments in Solid Tumors

Neil H. Segal, MD, PhD

Solid Tumor Session I9:00 am Colon Cancer Leonard B. Saltz, MD

10:00 am Melanoma Paul B. Chapman, MD

10:45 am Prostate Cancer Philip Kantoff, MD

11:30 am Kidney Cancer Robert J. Motzer, MD

12:15 pm Mesothelioma Marjorie G. Zauderer, MD

12:30 pm Lunch

1:15 pm Urothelial Cancer Dean F. Bajorin, MD, FACP

2:00 pm Testis Cancer Darren R. Feldman, MD

2:45 pm Uterine/Cervix/Other GYN Cancers Carol Aghajanian, MD

3:30 pm Break

3:45 pm Ovarian Cancer Rachel N. Grisham, MD

4:30 pm Breast Cancer/Surgery Hiram S. Cody III, MD, FACS

5:00 pm Breast Cancer/Radiation Therapy Beryl McCormick, MD, FACR

5:30 pm Esophageal and Gastric Cancer David H. Ilson, MD, PhD

6:15 pm Adjourn

Day 1 | Friday, March 6, 2020

6:30 am Breakfast

Solid Tumor Session II7:00 am Small Cell Lung Cancer W. Victoria Lai, MD

7:30 am Breast Cancer/Hormonal Therapy Devika Gajria, MD

8:00 am Breast Cancer/Advanced Disease Komal Jhaveri, MD, FACP

9:00 am Breast Cancer/Adjuvant Therapy Chau T. Dang, MD

10:00 am Carcinoma of Unknown Primary Anna M. Varghese, MD

10:30 am Break

10:45 am Hepatocellular Cancer and Cholangiocarcinoma

Ghassan K. Abou-Alfa, MD, MBA

11:30 am Pancreatic and Neuroendocrine Cancer Eileen M. O’Reilly, MD

12:15 pm Lunch Break

1:15 pm Non Small Cell Lung Cancer Gregory J. Riely, MD, PhD

2:00 pm Head and Neck, Thyroid, Non Melanoma Skin Cancer

David G. Pfister, MD

3:00 pm Anal/Rectal Cancer Andrea Cercek, MD

3:30 pm Break

3:45 pm Genetics Zsofia K. Stadler, MD

4:15 pm Sarcoma Mark A. Dickson, MD

4:45 pm Infectious Disease Susan Seo, MD

5:15 pm Adjourn

Day 2 | Saturday, March 7, 2020

6:45 am Breakfast

7:00 am CNS Tumors Christian Grommes, MD

Pharmacology7:30 am Pharmacology I Mrinal M. Gounder, MD

8:15 am Pharmacology II Mrinal M. Gounder, MD

9:20 am Break

Hematologic Oncology9:30 am CART cells Renier J. Brentjens, MD, PhD

10:30 am Low Grade NHL Andrew D. Zelenetz, MD, PhD

11:00 am CLL/SLL Anthony Mato, MD

11:30 am DLBCL/MCL/BL Paul Hamlin, MD

12:30 pm Lunch Break

1:15 pm HL/T Cell Alison Moskowitz, MD

2:15 pm Auto/Allo Craig Sauter, MD

3:15 pm AML/ALL Martin S. Tallman, MD

4:15 pm Break

4:30 pm MDS/MPN Michael J. Mauro, MD

5:30 pm Myeloma/Amyloid C. Ola Landgren, MD, PhD

6:30 pm Adjourn

Day 3 | Sunday, March 8, 2020

7:30 am Breakfast

Benign Hematologic Disorders8:00 am Thrombocytopenia, ITP and Beyond Gerald Soff, MD

9:00 am The Role of the New Direct Oral Anticoagulants in Practice

Simon Mantha, MD, MPH

10:00 am Approach to The Bleeding Patient Gerald Soff, MD

11:00 am Sickle Cell Disease, Thalassemia Jodi Mones, MD

12:00 pm Adjourn

Day 4 | Monday, March 9, 2020

LIVE SIMULCAST AVAILABLE

Unable to attend this course in person? We are pleased to offer a live simulcast option for this course. CME and ABIM MOC credit is offered for the live simulcast and pre-registration is required: mskcc.org/hemoncboardreview

Please note that the live simulcast is only available to non-MSK employees. MSK employees are welcome to register to attend this course in person.

AGENDA

Join the conversation: #MSKHemOncCME

This is best oncology/hematology review.

Excellent program! One of the best I have attended in my professional life... I am planning to come

back every year.

Excellent course! The best I've attended in 2018-2019.

This was my third year; I'm intending to return in the coming years.

2019 ATTENDEE REVIEWS

ACCREDITATIONMemorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation StatementMemorial Sloan Kettering Cancer Center designates this live activity for a maximum of 32.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition StatementSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 32.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty DisclosureIt is the policy of MSK to make every effort to insure balance, independence,objectivity, and scientific rigor in all continuing medical education activities which it provides as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity provided by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

REGISTRATIONRegistration Fees

Physicians (MDs, PhDs, and DOs) $1500

Residents, Fellows, Nurses, and Other Healthcare Providers $975

Industry Professionals* $2,625

Live Simulcast** $1,700

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities.**The live simulcast is only available to non-MSK employees. MSK employees are welcome to register to attend this course in person.

Register online:

mskcc.org/hemoncboardreviewCourse registration includes access to an online syllabus (with downloadable PDF files and video clips of the presentations), a USB flash drive*, as well as continental breakfast, lunch, and refreshment breaks. Please contact cme@mskcc.org at least one week prior to the course if you have any special dietary requests or require any specific accommodations.

Registration Discounts/Promotions

• MSK Alumni, MSK Cancer Alliance and Cancer Care Partner Discounts Available. Please contact cme@mskcc.org for more information or a promotion code.

• MSK employee registration is complimentary. However, you must complete course registration in order to attend this course.

Memorial Sloan Kettering Cancer CenterZuckerman Research Center417 East 68th StreetNew York, NY

MSK has negotiated special rates and amenities at select hotels in Manhattan. For more information, visit: mskcc.org/hemoncboardreview

ContactMemorial Sloan Kettering Cancer CenterContinuing Medical Educationmskcc.org/cmecme@mskcc.org

Location

*USB flash drive only available for non-MSK attendees.

8th Annual

Hematology and Medical Oncology Board Review:Contemporary Practice